CD8A and cancer: These findings suggest that the interplay between CD8+ T cells, lipid metabolism, and ferroptosis within the TME may hold the key to enhance cancer immunotherapy outcomes, shedding new light on potential strategies to harness the power of ferroptosis for targeted cancer treatment.